{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T04:39:45Z","timestamp":1773117585586,"version":"3.50.1"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s10072-025-08677-8","type":"journal-article","created":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T05:26:43Z","timestamp":1767850003000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Palmitoylethanolamide (PEA) in the treatment of restless legs syndrome: Rationale and case report"],"prefix":"10.1007","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-9132-7478","authenticated-orcid":false,"given":"Jean-Marc","family":"Bugnicourt","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,8]]},"reference":[{"key":"8677_CR1","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1016\/S1474-4422(18)30311-9","volume":"17","author":"C Trenkwalder","year":"2018","unstructured":"Trenkwalder C, Allen R, H\u00f6gl B et al (2018) Comorbidities, treatment, and pathophysiology in restless legs syndrome. Lancet Neurol 17:994\u20131005. https:\/\/doi.org\/10.1016\/S1474-4422(18)30311-9","journal-title":"Lancet Neurol"},{"key":"8677_CR2","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/j.neurol2018.06.002","volume":"174","author":"N Limousin","year":"2018","unstructured":"Limousin N, Flamand M, Schr\u00f6der C, Charley Monaca C (2018) French consensus: treatment of newly diagnosed restless legs syndrome. Rev Neurol (Paris) 174:515\u2013521. https:\/\/doi.org\/10.1016\/j.neurol2018.06.002","journal-title":"Rev Neurol (Paris)"},{"issue":"1","key":"8677_CR3","doi-asserted-by":"publisher","first-page":"137","DOI":"10.5664\/jcsm.11390","volume":"21","author":"JW Winkelman","year":"2025","unstructured":"Winkelman JW, Berkowski JA, DelRosso LM, Koo BB, Scharf MT, Sharon D, Zak RS, Kazmi U, Falck-Ytter Y, Shelgikar AV, Trotti LM, Walters AS (2025) Treatment of restless legs syndrome and periodic limb movement disorder: an American academy of sleep medicine clinical practice guideline. J Clin Sleep Med 21(1):137\u2013152. https:\/\/doi.org\/10.5664\/jcsm.11390","journal-title":"J Clin Sleep Med"},{"key":"8677_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.sleep.2025.106734","volume":"134","author":"R Ferri","year":"2025","unstructured":"Ferri R, Inoue Y, Trenkwalder C, Manconi M, Kushida CA (2025) Partial endorsement of \u201cTreatment of restless legs syndrome and periodic limb movement disorder: an American Academy of Sleep Medicine clinical practice guideline\u201d by the World Sleep Society. Sleep Med 134:106734. https:\/\/doi.org\/10.1016\/j.sleep.2025.106734","journal-title":"Sleep Med"},{"issue":"1","key":"8677_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.13078\/jsm.230030","volume":"21","author":"JM Bugnicourt","year":"2024","unstructured":"Bugnicourt JM (2024) Dopamine Agonists in the Treatment of Restless Legs Syndrome: Too Much of a Good Thing? J Sleep Med 21(1):1-5. https:\/\/doi.org\/10.13078\/jsm.230030","journal-title":"J Sleep Med"},{"key":"8677_CR6","doi-asserted-by":"publisher","unstructured":"Petrosino S, Di Marzo V (2017) The pharmacology of palmitoylethanolamide and first data on the therapeutic efficacy of some of its new formulations. Br J Pharmacol 174(11):1349-1365.\u00a0https:\/\/doi.org\/10.1111\/bph.13580","DOI":"10.1111\/bph.13580"},{"issue":"1","key":"8677_CR7","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1038\/s41572-021-00311-z","volume":"7","author":"M Manconi","year":"2021","unstructured":"Manconi M, Garcia-Borreguero D, Schormair B, Videnovic A, Berger K, Ferri R, Dauvilliers Y (2021) Restless legs syndrome. Nat Rev Dis Primers 7(1):80. https:\/\/doi.org\/10.1038\/s41572-021-00311-z","journal-title":"Nat Rev Dis Primers"},{"key":"8677_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.smrv.2022.101744","volume":"68","author":"FJ Jim\u00e9nez-Jim\u00e9nez","year":"2023","unstructured":"Jim\u00e9nez-Jim\u00e9nez FJ, Alonso-Navarro H, Garc\u00eda-Mart\u00edn E, Ag\u00fandez JAG (2023) Inflammatory factors and restless legs syndrome: a systematic review and meta-analysis. Sleep Med Rev 68:101744. https:\/\/doi.org\/10.1016\/j.smrv.2022.101744","journal-title":"Sleep Med Rev"},{"key":"8677_CR9","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/978-3-030-61663-2_13","volume":"1297","author":"I Ghorayeb","year":"2021","unstructured":"Ghorayeb I (2021) Cannabis for restless legs syndrome. Adv Exp Med Biol 1297:173\u2013181. https:\/\/doi.org\/10.1007\/978-3-030-61663-2_13","journal-title":"Adv Exp Med Biol"},{"key":"8677_CR10","doi-asserted-by":"publisher","unstructured":"Skaper SD, Facci L, Fusco M, Della Valle MF, Zusso M, Costa B, Giusti P (2014) Palmitoylethanolamide, a Naturally Occurring Disease-Modifying Agent in Neuropathic Pain. Inflammopharmacology 22:79\u201394. https:\/\/doi.org\/10.1007\/s10787-013-0191-7","DOI":"10.1007\/s10787-013-0191-7"},{"issue":"1","key":"8677_CR11","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1089\/can.2016.0030","volume":"2","author":"C Kramar","year":"2017","unstructured":"Kramar C, Loureiro M, Renard J, Laviolette SR (2017) Palmitoylethanolamide modulates GPR55 receptor signaling in the ventral hippocampus to regulate mesolimbic dopamine activity, social interaction, and memory processing. Cannabis Cannabinoid Res 2(1):8\u201320. https:\/\/doi.org\/10.1089\/can.2016.0030","journal-title":"Cannabis Cannabinoid Res"},{"issue":"2","key":"8677_CR12","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9020428","volume":"9","author":"S Beggiato","year":"2020","unstructured":"Beggiato S, Tomasini MC, Cassano T, Ferraro L (2020) Chronic oral palmitoylethanolamide administration rescues cognitive deficit and reduces neuroinflammation, oxidative stress, and glutamate levels in a transgenic murine model of Alzheimer\u2019s disease. J Clin Med 9(2):428. https:\/\/doi.org\/10.3390\/jcm9020428","journal-title":"J Clin Med"},{"key":"8677_CR13","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1186\/s12974-014-0136-0","volume":"11","author":"D Impellizzeri","year":"2014","unstructured":"Impellizzeri D, Bruschetta G, Cordaro M, Crupi R, Siracusa R et al (2014) Micronized\/ultramicronized palmitoylethanolamide displays superior oral efficacy compared to nonmicronized palmitoylethanolamide in a rat model of inflammatory pain. J Neuroinflammation 11:136. https:\/\/doi.org\/10.1186\/s12974-014-0136-0","journal-title":"J Neuroinflammation"},{"issue":"10","key":"8677_CR14","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.2174\/1871527314666150821102823","volume":"14","author":"Rosalba Siracusa","year":"2015","unstructured":"Siracusa Rosalba, Paterniti Irene, Impellizzeri Daniela, Cordaro Marika, Crupi Rosalia, Navarra Michele, Cuzzocrea Salvatore, Esposito Emanuela (2015) The association of palmitoylethanolamide with luteolin decreases neuroinflammation and stimulates autophagy in Parkinson\u2019s disease model. CNS Neurol Disord Drug Targets 14(10):1350\u201365. https:\/\/doi.org\/10.2174\/1871527314666150821102823","journal-title":"CNS Neurol Disord Drug Targets"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-025-08677-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10072-025-08677-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-025-08677-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T16:04:03Z","timestamp":1773072243000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10072-025-08677-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":14,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["8677"],"URL":"https:\/\/doi.org\/10.1007\/s10072-025-08677-8","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"value":"1590-1874","type":"print"},{"value":"1590-3478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"7 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from the patient included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The author has no conflict of interest related to this study to declare.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"121"}}